-
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.Research output: Contribution to journal › Article › Academic › peer-review
-
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma
Verkleij, C. P. M., O'Neill, C. A., Broekmans, M. E. C., Frerichs, K. A., Bruins, W. S. C., Duetz, C., Kruyswijk, S., Baglio, S. R., Skerget, S., de Oca, R. M., Zweegman, S., Verona, R. I., Mutis, T. & van de Donk, N. W. C. J., 15 Jul 2024, In: Clinical Cancer Research. 30, 14, p. 3006-3022 17 p.Research output: Contribution to journal › Article › Academic › peer-review
-
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
van de Donk, N. W. C. J., O’Neill, C., de Ruijter, M. E. M., Verkleij, C. P. M. & Zweegman, S., 1 Nov 2023, In: Current opinion in oncology. 35, 6, p. 601-611 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
